Seeking Alpha

CSL Behring Demonstrates Continued Commitment to Alpha-1 Community with Addition of ZEMAIRA® [Alpha1-Proteinase Inhibitor (Human)] 4- and 5-Gram Vials

- 4- and 5-gram ZEMAIRA ® vials may reduce the number of vials necessary for reconstitution, thereby providing convenience and lowering package waste KING OF PRUSSIA, Pa., Jan. 2, 2024 /PRNewswire/ -- ...
Monthly Prescribing Reference

Zemaira Now Available in 4- and 5-Gram Vials for Alpha

The dosing regimen for Zemaira is weight-based so the introduction of larger vial sizes reduces the number of reconstituted vials needed per dose. Zemaira (alpha 1-proteinase inhibitor [human]) is now ...
Drug Store News

FDA approves new vial size for CSL Behring immune treatment

KING OF PRUSSIA, Pa. — The Food and Drug Administration has approved a new vial size for a treatment for a rare immune system disorder. CSL Behring announced the approval of a 10-g, or 50-mL, vial ...
Nasdaq

New vial options deliver on CSL Behring's heritage of innovation by providing more alternatives to patients

KING OF PRUSSIA, Pa., April 25, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the US Food and Drug Administration (FDA) has approved 4- and 5-gram vial sizes for ...
Monthly Prescribing Reference

Larger Vial Size Approved for Hemophilia B Treatment Idelvion

The new 3500 IU vial size will help shorten the reconstitution time needed to prepare multiple vials for a similar dose. CSL Behring announced that Idelvion (coagulation factor IX [recombinant], ...